James Manuso

Insider Reports History

Entity
Individual
Location
5130 Route 212, Willow, NY
Signature
/s/ Dan Dearborn as Power of Attorney for James Manuso
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Manuso:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Director Common Stock 182K $178K $0.98 Jan 2, 2025 Direct
TuHURA Biosciences, Inc./NV Director Options (Right to Buy) 59.6K Jan 2, 2025 Direct
Ocuphire Pharma, Inc. Director Stock Option (Right to Buy) 35.2K Jun 11, 2024 Direct
Kintara Therapeutics, Inc. Director Common Stock 0 Oct 18, 2024 Direct

Insider Reports Filed by James Manuso

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HURA TuHURA Biosciences, Inc./NV Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
IRD Opus Genetics, Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 2 $0 4 Oct 22, 2024 Director
KTRA Kintara Therapeutics, Inc. Oct 18, 2024 0 $0 3 Oct 22, 2024 Director
OCUP Ocuphire Pharma, Inc. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
OCUP Ocuphire Pharma, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
OCUP Ocuphire Pharma, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
OCUP Ocuphire Pharma, Inc. Apr 19, 2023 1 $0 4 Apr 21, 2023 Director
OCUP Ocuphire Pharma, Inc. Jan 11, 2023 1 $0 4 Jan 12, 2023 Director
OCUP Ocuphire Pharma, Inc. Oct 11, 2022 2 $0.08 4 Oct 12, 2022 Director
OCUP Ocuphire Pharma, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
OCUP Ocuphire Pharma, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
OCUP Ocuphire Pharma, Inc. May 20, 2022 1 $9.95K 4 May 24, 2022 Director
OCUP Ocuphire Pharma, Inc. Nov 18, 2021 1 $7K 4 Nov 22, 2021 Director
OCUP Ocuphire Pharma, Inc. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director